Skip to content

Repetitive Transcranial Magnetic Stimulation on Dysphagia in the Stroke Patient

Effects of Repetitive Transcranial Magnetic Stimulation on Dysphagia in Individuals With Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05861596
Enrollment
40
Registered
2023-05-17
Start date
2022-11-23
Completion date
2023-12-30
Last updated
2023-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia, Repetitive Transcranial Magnetic Stimulation, Stroke

Brief summary

Participants suffered from acute stroke with dysphagia in single hospital who were determined by CT/MRI and clinical evaluation. Current project will recruit participants and randomize into two groups.One group will receive NMES, traditional swallowing therapy and rTMS therapy five times per week for 2 weeks ; Another group will receive NMES and traditional swallowing therapy with shame rTMS five times per week for 2 weeks. FEES and SSA were used for evaluated swallowing function before the therapy and after 2 weeks therapy.

Detailed description

Participants suffered from acute stroke with dysphagia in single hospital who were determined by CT/MRI and clinical evaluation. The aim of this study is to compare the effects of rTMS, NMES and conventional swallowing therapy to those of sham rTMS, NMES and conventional swallowing therapy. One group will receive NMES, to sham One group will receive NMES,traditional swallowing therapy and rTMS therapy five times per week for 2 weeks ; Another group will receive NMES and traditional swallowing therapy with shame rTMS five times per week for 2 weeks. MEP character, FEES, degrees of dysphagia, FOIS, and SSA were used for evaluated swallowing function before the therapy and after 2 weeks therapy.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation

Participants suffered from acute stroke with dysphagia in single hospital who were determined by CT/MRI and clinical evaluation. The aim of this study is to compare the effects of rTMS, Neuromuscular electrical stimulation (NMES) and conventional swallowing therapy to those of sham rTMS, Neuromuscular electrical stimulation(NMES) and conventional swallowing therapy. One group will receive Neuromuscular electrical stimulation(NMES), to sham One group will receive Neuromuscular electrical stimulation(NMES),traditional swallowing therapy and rTMS therapy five times per week for 2 weeks ; Another group will receive Neuromuscular electrical stimulation(NMES) and traditional swallowing therapy with shame rTMS five times per week for 2 weeks. MEP character, FEES, degrees of dysphagia, FOIS, and SSA were used for evaluated swallowing function before the therapy and after 2 weeks therapy.

DEVICENeuromuscular electrical stimulation combined with conventional swallowing training

Participants suffered from acute stroke with dysphagia in single hospital who were determined by CT/MRI and clinical evaluation. The aim of this study is to compare the effects of rTMS, Neuromuscular electrical stimulation (NMES) and conventional swallowing therapy to those of sham rTMS, Neuromuscular electrical stimulation(NMES) and conventional swallowing therapy. One group will receive Neuromuscular electrical stimulation(NMES), to sham One group will receive Neuromuscular electrical stimulation(NMES),traditional swallowing therapy and rTMS therapy five times per week for 2 weeks ; Another group will receive Neuromuscular electrical stimulation(NMES) and traditional swallowing therapy with shame rTMS five times per week for 2 weeks. MEP character, FEES, degrees of dysphagia, FOIS, and SSA were used for evaluated swallowing function before the therapy and after 2 weeks therapy.

Sponsors

Taipei Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. stroke 2. Onset time at least for one week,area not be limited. 3. Patient was first time stroke patient without obvious infection condition. 4. Patients with dysphagia in the stroke who were diagnosed by neurologist and CT/MRI in our institute. Patient was clear with adequate motivation and could cooperate the whole therapy and FEES evaluation.

Exclusion criteria

1. Lower motor neuron disease, such as autonomic dysreflexia, facial palsy, hyhoid muscle denervation. 2. Mental status unstable, mental retardation, schizophrenia, bipolar disease were be excluded. 3. Metal implantation of head, ventroperotoneal shunt or any seizure history, pacemaker, as well as head and neck cancer. 4. Allergy to specific subjects 5. Cognition impairment 6. Alcohol or drugs abuse 7. Afraid of the noise of rTMS.

Design outcomes

Primary

MeasureTime frameDescription
Change of baseline Amplitude of Motor evoked potentials (MEP) at 2 weeksone day before intervention, 1 day after intervention.Onset to peak amplitude of Motor evoked potentials (MEP).The amplitude of motor evoked potentials (MEPs) elicited by transcranial magnetic stimulation (TMS) is a common yet highly variable measure of corticospinal excitability.
Change from baseline in The Fiberoptic Endoscopic Dysphagia Severity Scale (FEDSS) at 2 weeksone day before intervention, 1 day after interventionThe Fiberoptic Endoscopic Dysphagia Severity Scale (FEDSS): Stroke-related dysphagia was divided into a six-point FEDSS with 1 score for the best and 6 scores for the worst.
Change of baseline Standardized Swallowing Assessment (SSA) at 2 weeksone day before intervention, 1 day after interventionIn this study, SSA was executed before and after intervention. SSA is a standard of universal screening of all stroke patients within 24 hours of admission. And SSA comprises three sections and was designed to terminate if a problem was encountered. The first section checked whether the patient was physically capable of screening; sections 2 and 3 comprised the main screening test. Volitional cough, saliva control, oral motor dexterity, respiratory compromise and phonation were first evaluated; if no problems were elicited, the ability to swallow water was observed.
Change of baseline Latency of Motor evoked potentials (MEP) at 2 weeksone day before intervention, 1 day after interventionOnset latency of MEP, The latency, however, may provide information about the stress in damaged motor pathways.
Change from baseline in Fiberoptic Endoscopic Examination of Swallowing (FEES) at 2 weeksone day before intervention, 1 day after interventionIn this study, FEES is executed before and after intervention. The assessment of FEES is as follows. Hyodo-score: for predicting aspiration with moderate sensitivity and high specificity. This method consists of four parameters; These four parameters are each scored 0-3 on a 4 point scale (0; normal, 1; mildly impaired, 2; moderately impaired, 3; severely impaired). The Hyodo score is expressed as the sum of scores for each of the four parameters, ranging 0- 12. Patients with a score of less than 5 were assessed as having normal swallowing function. Patients with a score of more than 8 had severe swallowing dysfunction and would not be allowed any oral intake.

Secondary

MeasureTime frameDescription
Change of Functional Oral Intake Scale (FOIS) at 2 weeksone day before intervention, 1 day after interventionFunctional Oral Intake Scale
Change of baseline modified water swallowing test at 2 weeksone day before intervention, 1 day after interventionmodified water swallowing test
Change of baseline Degree of dysphagia at 2 weeksone day before intervention, 1 day after interventionScore of degree of dysphagia, score 0 shows normal swallowing, score 1 is able to swallow , some solid food, score 2 is able to swallow semi-liquid food, score 3 is able to swallow liquids only, score 4 exhibits absolute dysphagia.

Countries

Taiwan

Contacts

Primary ContactChien-Hung Lai, MD, PhD
chlai@tmu.edu.tw02-27372181
Backup ContactChieh Chen, MD
garyrbc@gmail.com+886933235048

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026